Regeneron Pharmaceuticals, Inc.
MX ˙ BMV ˙ US75886F1075
SecurityMX:REGN / Regeneron Pharmaceuticals, Inc.
InstitutionHighTower Advisors, LLC
Latest Disclosed Ownership58,925 shares
Latest Disclosed Value $ 45,531,200
HighTower Advisors, LLC ownership in REGN / Regeneron Pharmaceuticals, Inc.

On May 5, 2026 - HighTower Advisors, LLC filed a 13F-HR form disclosing ownership of 58,925 shares of Regeneron Pharmaceuticals, Inc. (MX:REGN) valued at $45,531,200 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 46,087 shares of Regeneron Pharmaceuticals, Inc.. This represents a change in shares of 27.86% during the quarter.

HighTower Advisors, LLC has a history of taking positions in derivatives of the underlying security (REGN) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:REGN / Regeneron Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 58,925 12,838 27.86 45,531 27.99 0.0483
2026-02-06 2025-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 46,087 356 0.78 35,573 38.34 0.0389
2025-11-07 2025-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 45,731 1,944 4.44 25,715 11.86 0.0292
2025-08-11 2025-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 43,787 12,514 40.02 22,988 15.91 0.0288
2025-05-13 2025-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 31,273 971 3.20 19,834 -8.11 0.0269
2025-02-07 2024-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 30,302 -2,723 -8.25 21,585 -37.63 0.0295
2024-11-14 2024-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 33,025 -2,351 -6.65 34,604 -6.67 0.0494
2024-08-13 2024-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 35,376 1,204 3.52 37,079 12.17 0.0573
2024-05-06 2024-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 34,172 -409 -1.18 33,055 8.05 0.0535
2024-02-12 2023-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 34,581 -606 -1.72 30,593 5.71 0.0513
2023-11-08 2023-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 35,187 818 2.38 28,941 17.31 0.0544
2023-08-14 2023-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 34,369 8,751 34.16 24,670 17.39 0.0486
2023-05-12 2023-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 25,618 -5,140 -16.71 21,016 -5.05 0.0458
2023-02-09 2022-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 30,758 3,125 11.31 22,134 16.46 0.0506
2022-11-09 2022-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 27,633 1,361 5.18 19,005 21.82 0.0509
2022-08-10 2022-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 26,272 -2,907 -9.96 15,601 -23.06 0.0403
2022-05-12 2022-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 29,179 -611 -2.05 20,276 7.91 0.0452
2022-02-10 2021-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 29,790 7,908 36.14 18,789 42.20 0.0412
2021-11-12 2021-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 21,882 1,363 6.64 13,213 15.35 0.0354
2021-08-06 2021-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 20,519 14,383 234.40 11,455 294.32 0.0332
2021-05-10 2021-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 6,136 -4,747 -43.62 2,905 -44.19 0.0092
2021-02-10 2020-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 10,883 538 5.20 5,205 -10.10 0.0217
2020-11-13 2020-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 10,345 -1,137 -9.90 5,790 -18.63 0.0280
2020-08-10 2020-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 11,482 -449 -3.76 7,116 23.63 0.0388
2020-05-21 2020-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 11,931 -1,227 -9.33 5,756 15.19 0.0373
2020-02-14 2019-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 13,158 3,083 30.60 4,997 79.30 0.0295
2019-11-12 2019-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 10,075 59 0.59 2,787 -11.72 0.0152
2019-08-13 2019-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 10,016 -8,840 -46.88 3,157 -59.04 0.0188
2019-05-15 2019-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 18,856 5,575 41.98 7,707 56.04 0.0515
2019-02-14 2018-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 13,281 -15,699 -54.17 4,939 -57.71 0.0379
2018-11-09 2018-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 28,980 10,223 54.50 11,679 81.77 0.0842
2018-08-14 2018-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 18,757 6,363 51.34 6,425 51.28 0.0503
2018-05-15 2018-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 12,394 2,426 24.34 4,247 12.32 0.0356
2018-02-14 2017-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 9,968 -1,092 -9.87 3,781 -23.55 0.0310
2017-11-14 2017-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 11,060 2,457 28.56 4,946 18.69 0.0422
2017-09-22 2017-06-30 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 8,603 1,085 14.43 4,167 42.90 0.0373
2017-08-14 2017-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 8,603 1,085 4,167
2017-05-15 2017-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 7,518 2,625 53.65 2,916 62.00 0.0279
2017-02-10 2016-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 4,893 698 16.64 1,800 7.08 0.0196
2016-11-14 2016-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 4,195 863 25.90 1,681 45.04 0.0195
2016-08-11 2016-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 3,332 -5,719 -63.19 1,159 -64.51 0.0147
2016-05-16 2016-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 9,051 -7,387 -44.94 3,266 -63.44 0.0107
2016-05-18 2015-12-31 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 16,438 4,815 41.43 8,934 65.05 0.1061
2016-02-12 2015-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 16,438 8,934
2015-11-16 2015-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 11,623 1,087 10.32 5,413 0.65 0.0717
2015-08-11 2015-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 10,536 3,787 56.11 5,378 76.50 0.0862
2015-05-15 2015-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 6,749 542 8.73 3,047 19.68 0.0453
2015-02-17 2014-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 6,207 167 2.76 2,546 16.90 0.0390
2014-11-14 2014-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 6,040 1,144 23.37 2,178 57.48 0.0368
2014-08-13 2014-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 4,896 187 3.97 1,383 -2.19 0.0240
2014-05-15 2014-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 4,709 1,076 29.62 1,414 41.40 0.0276
2014-02-14 2013-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 3,633 3,633 1,000 0.0206
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-08-11 2025-06-30 13F REGENERON PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-13 2025-03-31 13F REGENERON PHARMACEUTICALS COM Call 200 3 n/a n/a n/a
2024-11-14 2024-09-30 13F REGENERON PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-13 2024-06-30 13F REGENERON PHARMACEUTICALS COM Call 200 7 n/a n/a n/a
2018-05-15 2018-03-31 13F REGENERON PHARMACEUTICALS COM Call 0 -100.00 0 n/a n/a n/a
2018-02-14 2017-12-31 13F REGENERON PHARMACEUTICALS COM Call 1,000 0.00 0 -100.00 n/a n/a n/a
2017-11-14 2017-09-30 13F REGENERON PHARMACEUTICALS COM Call 1,000 0.00 34 -12.82 n/a n/a n/a
2017-09-22 2017-06-30 13F/A REGENERON PHARMACEUTICALS COM Call 1,000 39 n/a n/a n/a
2017-08-14 2017-06-30 13F REGENERON PHARMACEUTICALS COM Call 1,000 39 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-05-11 2023-03-31 13F REGENERON PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-09 2022-12-31 13F REGENERON PHARMACEUTICALS COM Put 400 1,190 n/a n/a n/a
2021-05-10 2021-03-31 13F REGENERON PHARMACEUTICALS COM Put 0 -100.00 0 n/a n/a n/a
2021-02-10 2020-12-31 13F REGENERON PHARMACEUTICALS COM Put 1 0 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.